Wade Hull
Chief Tech/Sci/R&D Officer at CRESCITA THERAPEUTICS INC.
Net worth: 12 563 $ as of 31/05/2024
Wade Hull active positions
| Companies | Position | Start | End |
|---|---|---|---|
| CRESCITA THERAPEUTICS INC. | Chief Tech/Sci/R&D Officer | 01/03/2016 | - |
Career history of Wade Hull
Former positions of Wade Hull
| Companies | Position | Start | End |
|---|---|---|---|
| UTAH MEDICAL PRODUCTS, INC. | Corporate Officer/Principal | 01/05/1996 | 01/12/1996 |
| NUVO PHARMACEUTICALS INC. | Chief Tech/Sci/R&D Officer | - | - |
ZARS Pharma, Inc.
 ZARS Pharma, Inc. Pharmaceuticals: MajorHealth Technology ZARS Pharma, Inc. develops and distributes drugs. It is a specialty pharmaceutical company focused on the development and commercialization of topically administered drugs, primarily for the treatment of pain, using its proprietary drug delivery technologies. The company was founded by Jie Zhang, Theodore H. Stanley, Larry D. Rigby and Michael A. Ashburn in 1996 and is headquartered in Salt Lake City, UT. | Chief Tech/Sci/R&D Officer | 01/08/1998 | - |
Training of Wade Hull
| University of Utah | Graduate Degree |
Statistics
International
| United States | 4 |
| Canada | 3 |
Operational
| Chief Tech/Sci/R&D Officer | 3 |
| Graduate Degree | 1 |
| Undergraduate Degree | 1 |
Sectoral
| Health Technology | 5 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| UTAH MEDICAL PRODUCTS, INC. | Health Technology |
| CRESCITA THERAPEUTICS INC. | Health Technology |
| Private companies | 2 |
|---|---|
ZARS Pharma, Inc.
ZARS Pharma, Inc. Pharmaceuticals: MajorHealth Technology ZARS Pharma, Inc. develops and distributes drugs. It is a specialty pharmaceutical company focused on the development and commercialization of topically administered drugs, primarily for the treatment of pain, using its proprietary drug delivery technologies. The company was founded by Jie Zhang, Theodore H. Stanley, Larry D. Rigby and Michael A. Ashburn in 1996 and is headquartered in Salt Lake City, UT. | Health Technology |
Nuvo Pharmaceuticals, Inc.
 Nuvo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Nuvo Pharmaceuticals, Inc. is a pharmaceutical company, which is engaged in developing innovative therapeutic pharmaceutical products. It operates through the following segments: Commercial Business, Production and Service Business, and Licensing and Royalty Business. The Commercial Business segment includes Blexten, Cambia, the canadian business for Resultz and Suvexx, and mature assets. The Production and Service Business segment supplies Pennsaid to Horizon for the U.S. market and is engaged in ongoing partnering efforts for Pennsaid. The Licensing and Royalty Business segment engages in the selling of Vimovo. The company was founded on August 22, 1983 and is headquartered in Mississauga, Canada. | Health Technology |
- Stock Market
- Insiders
- Wade Hull
- Experience
